2002
DOI: 10.1128/iai.70.1.360-367.2002
|View full text |Cite
|
Sign up to set email alerts
|

In Vivo Rho GTPase-Activating Protein Activity of Pseudomonas aeruginosa Cytotoxin ExoS

Abstract: ExoS is a bifunctional type III cytotoxin secreted by Pseudomonas aeruginosa, which comprises a C-terminal ADP ribosyltransferase domain and an N-terminal Rho GTPase-activating protein (GAP) domain. In vitro, ExoS is a Rho GAP for Rho, Rac, and Cdc42; however, the in vivo modulation of Rho GTPases has not been addressed. Using a transient transfection system and delivery by P. aeruginosa, interactions were examined between the Rho GAP domain of ExoS and Rho GTPases in CHO cells. Rho GTPases were expressed as g… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
82
1

Year Published

2004
2004
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 86 publications
(85 citation statements)
references
References 34 publications
2
82
1
Order By: Relevance
“…ExoS is a bifunctional toxin containing a GTPase-activating protein (GAP) domain and an ADPribosyltransferase (ADPRT) domain. The amino-terminal GAP activity acts on Rho family GTPases while the carboxylterminal ADPRT activity is directed towards Ras and other host-cell proteins (Fraylick et al, 2001;Goehring et al, 1999;Henriksson et al, 2000Henriksson et al, , 2002Krall et al, 2002;Olson et al, 1999;Rocha et al, 2003;Vincent et al, 1999). As a result of these enzymic activities, intoxication with ExoS is associated with several observable phenotypes, including cytotoxicity and inhibition of bacterial internalization by both phagocytic and non-phagocytic mammalian cells (Cowell et al, 2000;Fleiszig et al, 1997;Frithz-Lindsten et al, 1997;Henriksson et al, 2000;Kaufman et al, 2000;Olson et al, 1997Olson et al, , 1999Pederson & Barbieri, 1998;Vincent et al, 1999).…”
Section: Introductionmentioning
confidence: 99%
“…ExoS is a bifunctional toxin containing a GTPase-activating protein (GAP) domain and an ADPribosyltransferase (ADPRT) domain. The amino-terminal GAP activity acts on Rho family GTPases while the carboxylterminal ADPRT activity is directed towards Ras and other host-cell proteins (Fraylick et al, 2001;Goehring et al, 1999;Henriksson et al, 2000Henriksson et al, , 2002Krall et al, 2002;Olson et al, 1999;Rocha et al, 2003;Vincent et al, 1999). As a result of these enzymic activities, intoxication with ExoS is associated with several observable phenotypes, including cytotoxicity and inhibition of bacterial internalization by both phagocytic and non-phagocytic mammalian cells (Cowell et al, 2000;Fleiszig et al, 1997;Frithz-Lindsten et al, 1997;Henriksson et al, 2000;Kaufman et al, 2000;Olson et al, 1997Olson et al, , 1999Pederson & Barbieri, 1998;Vincent et al, 1999).…”
Section: Introductionmentioning
confidence: 99%
“…The P. aeruginosa TTSS has in recent years been shown to be linked to increased severity of nosocomial pneumonia in humans (19,42) and to be important for pathogenesis in murine models of lung (2,49) and eye (29) infections. The effector proteins of the P. aeruginosa TTSS include ExoS and ExoT, which function as both ADP-ribosyltransferases and GTPase-activating proteins (15,26,27); ExoY, which is an adenylate cyclase (58); and ExoU, which has recently been shown to be a lipase (13,44). Interestingly, the exoS and exoU genes appear to be mutually exclusive: P. aeruginosa strains have either one or the other (14,42,57).…”
mentioning
confidence: 99%
“…The activity of each effector is dependent upon interaction with a cofactor present in eukaryotic but not prokaryotic cells. ExoS and ExoT are bifunctional enzymes that possess both Rho GTPase-activating protein and ADP-ribosyltransferase activities (23,25,51). The ADP ribosylation of eukaryotic proteins by ExoS and ExoT requires activation by members of the 14-3-3 family of scaffolding proteins (13).…”
mentioning
confidence: 99%